Literature DB >> 20105287

Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan.

Kuo-Piao Chung1, Yun-Jau Chang, Mei-Shu Lai, Raymond Nien-Chen Kuo, Skye H Cheng, Li-Tzong Chen, Reiping Tang, Tsang-Wu Liu, Ming-Jium Shieh.   

Abstract

BACKGROUND: Although performance measurement for assessing care quality is an emerging area, a system for measuring the quality of cancer care at the hospital level has not been well developed. The purpose of this study was to develop organization-based core measures for colorectal cancer patient care and apply these measures to compare hospital performance.
METHODS: The development of core measures for colorectal cancer has undergone three stages including a modified Delphi method. The study sample originated from 2004 data in the Taiwan Cancer Database, a national cancer data registry. Eighteen hospitals and 5585 newly diagnosed colorectal cancer patients were enrolled in this study. We used indicator-based and case-based approaches to examine adherences simultaneously.
RESULTS: The final core measure set included seventeen indicators (1 pre-treatment, 11 treatment-related and 5 monitoring-related). There were data available for ten indicators. Indicator-based adherence possesses more meaningful application than case-based adherence for hospital comparisons. Mean adherence was 85.8% (79.8% to 91%) for indicator-based and 82.8% (77.6% to 88.9%) for case-based approaches. Hospitals performed well (>90%) for five out of eleven indicators. Still, the performance across hospitals varied for many indicators. The best and poorest system performance was reflected in indicators T5-negative surgical margin (99.3%, 97.2%-100.0%) and T7-lymph nodes harvest more than twelve(62.7%, 27.6%-92.2%), both of which related to surgical specimens.
CONCLUSIONS: In this nationwide study, quality of colorectal cancer care still shows room for improvement. These preliminary results indicate that core measures for cancer can be developed systematically and applied for internal quality improvement.

Entities:  

Mesh:

Year:  2010        PMID: 20105287      PMCID: PMC2835701          DOI: 10.1186/1472-6963-10-27

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  30 in total

1.  Organization-based performance measures of cancer care quality: core measure development for breast cancer in Taiwan.

Authors:  K-P Chung; M-S Lai; S H Cheng; S-T Tang; C C Huang; A-L Cheng; P-C Hsieh
Journal:  Eur J Cancer Care (Engl)       Date:  2008-01       Impact factor: 2.520

2.  On the road to improving the quality of breast cancer care: a distance still to travel.

Authors:  Jeanne S Mandelblatt; Arnold L Potosky
Journal:  Med Care       Date:  2008-08       Impact factor: 2.983

3.  Measuring the quality of healthcare systems using composites.

Authors:  Bruce Guthrie
Journal:  BMJ       Date:  2008-08-13

4.  Quality of care for lung cancer in Taiwan: a pattern of care based on core measures in the Taiwan Cancer Database registry.

Authors:  Chun-Ru Chien; Chun-Ming Tsai; Siew-Tzuh Tang; Kuo-Piao Chung; Chao-Hua Chiu; Mei-Shu Lai
Journal:  J Formos Med Assoc       Date:  2008-08       Impact factor: 3.282

5.  Empirically derived composite measures of surgical performance.

Authors:  Douglas O Staiger; Justin B Dimick; Onur Baser; Zhaohui Fan; John D Birkmeyer
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

6.  Lymph node evaluation as a colon cancer quality measure: a national hospital report card.

Authors:  Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; Mark S Talamonti; David P Winchester; Thomas R Russell; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

7.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

8.  Quality of care issues in colorectal cancer.

Authors:  Michael J Leonardi; Marcia L McGory; Clifford Y Ko
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

9.  Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?

Authors:  Jiping Wang; Mahmoud Kulaylat; Howard Rockette; James Hassett; Ashwani Rajput; Kelli Bullard Dunn; Merril Dayton
Journal:  Ann Surg       Date:  2009-04       Impact factor: 12.969

10.  Self reported receipt of care consistent with 32 quality indicators: national population survey of adults aged 50 or more in England.

Authors:  Nicholas Steel; Max Bachmann; Susan Maisey; Paul Shekelle; Elizabeth Breeze; Michael Marmot; David Melzer
Journal:  BMJ       Date:  2008-08-13
View more
  9 in total

1.  Evaluation of lymph nodes in patients with colon cancer undergoing colon resection: a population-based study.

Authors:  Yun-Jau Chang; Yao-Jen Chang; Li-Ju Chen; Kuo-Piao Chung; Mei-Shu Lai
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  Can composite performance measures predict survival of patients with colorectal cancer?

Authors:  Kuo-Piao Chung; Li-Ju Chen; Yao-Jen Chang; Yun-Jau Chang
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

3.  Risk groups defined by Recursive Partitioning Analysis of patients with colorectal adenocarcinoma treated with colorectal resection.

Authors:  Yun-Jau Chang; Li-Ju Chen; Yao-Jen Chang; Kuo-Piao Chung; Mei-Shu Lai
Journal:  BMC Med Res Methodol       Date:  2012-01-03       Impact factor: 4.615

Review 4.  Benchmarking specialty hospitals, a scoping review on theory and practice.

Authors:  A Wind; W H van Harten
Journal:  BMC Health Serv Res       Date:  2017-04-04       Impact factor: 2.655

5.  DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia.

Authors:  Jonathan M Hernandez; Erin M Siegel; Bridget Riggs; Steven Eschrich; Abul Elahi; Xiaotao Qu; Abidemi Ajidahun; Anders Berglund; Domenico Coppola; William M Grady; Anna R Giuliano; David Shibata
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

6.  Development and testing of indicators to measure coordination of clinical information and management across levels of care.

Authors:  Marta-Beatriz Aller; Ingrid Vargas; Jordi Coderch; Sebastià Calero; Francesc Cots; Mercè Abizanda; Joan Farré; Josep Ramon Llopart; Lluís Colomés; María Luisa Vázquez
Journal:  BMC Health Serv Res       Date:  2015-08-13       Impact factor: 2.655

7.  Clinical and pathologic factors affecting lymph node yields in colorectal cancer.

Authors:  Ta-Wen Hsu; Hsin-Ju Lu; Chang-Kuo Wei; Wen-Yao Yin; Chun-Ming Chang; Wen-Yen Chiou; Moon-Sing Lee; Hon-Yi Lin; Yu-Chieh Su; Shih-Kai Hung
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

8.  Quality indicators for responsible use of medicines: a systematic review.

Authors:  Kenji Fujita; Rebekah J Moles; Timothy F Chen
Journal:  BMJ Open       Date:  2018-07-16       Impact factor: 2.692

9.  Latent composite indicators for evaluating adherence to guidelines in patients with a colorectal cancer diagnosis.

Authors:  Rossella Murtas; Adriano Decarli; Maria Teresa Greco; Anita Andreano; Antonio Giampiero Russo
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.